The
Cleveland Plain Dealer (1/14,
Townsend, 966K) reports that five physicians “who were part of the panel that
issued updated treatment guidelines for high blood pressure last month” have
written an article in the Annals of Internal Medicine in which they come “out
against one of the recommendations saying that there is insufficient evidence to
support it.” These “physicians – part of the 17-member panel Eighth Joint
National Committee, or JNC 8 – are against raising the threshold at which older
adults begin taking medication to control their blood pressure. The majority of
the panel voted to raise the systolic blood pressure...from 140 to 150 for
people age 60 and older who don’t have chronic kidney disease or diabetes.”
On
its website, TIME (1/14,
Sifferlin, 21.77M) reports that they wrote, “We, the panel minority, believed
that evidence was insufficient to increase the [target systolic blood pressure]
goal from its current level of less than 140 mm Hg because of concern that
increasing the goal may cause harm by increasing the risk for CVD
[cardiovascular disease] and partially undoing the remarkable progress in
reducing cardiovascular mortality in Americans older than 60 years.”
CardioSource (1/14, 2K) reports, “The editorial does agree, however, with recommendations that SBP < 150 mmHg for frail individuals ≥ age 80 is a reasonable alternative approach to addressing concerns that elderly patients are at higher risk for treatment-related serious events.” Additionally, “the authors...add that ‘a target SBP less than 140 mmHg for patients less than 80 years would also be in line with guidelines from Europe, Canada, the ACCF/AHA, the United Kingdom, and the ASH/ISH.’”
MedPage Today (1/14, Neale, 122K)
reports that while “the impact of the latest guidance – and the disagreement
among the panel members – remains unclear...it is possible that clinicians will
wait for hypertension recommendations from the American Heart Association and
the American College of Cardiology, which are expected to be completed by early
2015.” Medscape (1/14, Wood,
164K) also covers the story.
Posted
by: Steven Almany M.D.
No comments:
Post a Comment